- Home
- FULT vs OGN Comparison
FULT vs OGN Comparison
Compare FULT & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FULT
- OGN
- Stock Information
- Founded
- FULT 1882
- OGN 1923
- Country
- FULT United States
- OGN United States
- Employees
- FULT N/A
- OGN N/A
- Industry
- FULT Major Banks
- OGN Biotechnology: Pharmaceutical Preparations
- Sector
- FULT Finance
- OGN Health Care
- Exchange
- FULT Nasdaq
- OGN Nasdaq
- Market Cap
- FULT 3.9B
- OGN 4.0B
- IPO Year
- FULT N/A
- OGN N/A
- Fundamental
- Price
- FULT $20.84
- OGN $15.10
- Analyst Decision
- FULT Hold
- OGN Hold
- Analyst Count
- FULT 5
- OGN 3
- Target Price
- FULT $19.20
- OGN $21.33
- AVG Volume (30 Days)
- FULT 854.3K
- OGN 2.9M
- Earning Date
- FULT 01-14-2025
- OGN 02-13-2025
- Dividend Yield
- FULT 3.32%
- OGN 7.65%
- EPS Growth
- FULT N/A
- OGN 120.97
- EPS
- FULT 1.58
- OGN 5.04
- Revenue
- FULT $1,083,452,000.00
- OGN $6,409,000,000.00
- Revenue This Year
- FULT N/A
- OGN $3.11
- Revenue Next Year
- FULT $3.80
- OGN $2.55
- P/E Ratio
- FULT $12.97
- OGN $2.93
- Revenue Growth
- FULT 4.83
- OGN 4.21
- 52 Week Low
- FULT $13.87
- OGN $13.14
- 52 Week High
- FULT $22.49
- OGN $23.10
- Technical
- Relative Strength Index (RSI)
- FULT 51.82
- OGN 42.91
- Support Level
- FULT $20.50
- OGN $14.53
- Resistance Level
- FULT $21.39
- OGN $15.41
- Average True Range (ATR)
- FULT 0.46
- OGN 0.52
- MACD
- FULT -0.16
- OGN 0.02
- Stochastic Oscillator
- FULT 28.89
- OGN 31.89
About FULT Fulton Financial Corporation
Fulton Financial is a U.S.-based financial services holding company that operates in five states: Pennsylvania, Delaware, Maryland, New Jersey, and Virginia. It offers a range of consumer and commercial banking products and services, such as checking and savings deposit products and loan products. It offers consumer and commercial banking products and services, as well as wealth management products and services. The bank derives its revenue from non-interest income, led by its Wealth Management division.
About OGN Organon & Co.
Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars, and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.